West Pharmaceutical Services Inc. Company Profile
NYSE: WSTHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 8, 3:39 PM ET
West Pharmaceutical Services at a glance
West Pharmaceutical Services Inc. (NYSE: WST) is a Medical/Dental Instruments company in the Health Care sector headquartered in Exton, PA. West Pharmaceutical Services is led by Mr. Michel Lagarde and employs about 10,800 people. At a market capitalization of $26.22 billion, it is considered a large-cap company.
WST is a member of the SP500. Its SEC Central Index Key (CIK) is 0000105770, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does West Pharmaceutical Services do?
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Business description based on the company's public filings.
Company information
- Legal name
- West Pharmaceutical Services Inc.
- Ticker
- NYSE: WST
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Michel Lagarde
- Employees
- 10,800
- Headquarters
- 530 Herman O. West Drive, Exton, PA, United States
- Phone
- 610 594 2900
- Website
- westpharma.com
- Market cap
- $26.22B
- SEC CIK
- 0000105770
- Latest annual report
- 10-K · Feb 17, 2026
Index membership
Companies similar to West Pharmaceutical Services
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DXCMDexCom Inc. | 84.41 | +0.12% | $31.85B | vs WST |
| RMDResMed Inc. | 226.48 | +0.22% | $31.85B | vs WST |
| SOLVSolventum Corporation | 86.58 | +0.82% | $14.74B | vs WST |
| PENPenumbra Inc. | 317.18 | +0.26% | $12.49B | vs WST |
| BAXBaxter International Inc. | 23.94 | -0.13% | $12.38B | vs WST |
| GMEDGlobus Medical Inc. Class A | 73.36 | -0.53% | $9.85B | vs WST |
| GKOSGlaukos Corporation | 160.23 | -6.94% | $9.45B | vs WST |
| PODDInsulet Corporation | 134.34 | -0.01% | $9.32B | vs WST |